This website uses cookies to ensure you get the best experience on our website.
View our privacy policy.
The table below presents a summary of perpetual preferred stock outstanding as of October 23, 2024
Name (1) | CUSIP | Ticker | Issue Date | Per Annum Dividend Rate | Dividend Payment Dates | Dividend Type | Callable on or After (2) |
---|---|---|---|---|---|---|---|
Series B | 060505203 | n/a | Jun 1997 | 7.000% | Jan 25, Apr 25, Jul 25, Oct 25 | Cumulative | Non-callable |
Series E *,(3) | 060505815 | BAC PrE | Nov 2006 | Greater of 3-month CME Term SOFR + 61.161 bps or 4% | Feb 15, May 15, Aug 15, Nov 15 | Non-cumulative | 11/15/2011 |
Series F *,(4) | 060505377 | n/a | Mar 2012 | Greater of 3-month CME Term SOFR + 66.161 bps or 4% | Mar 15, Jun 15, Sep 15. Dec 15 | Non-cumulative | 3/15/2012 |
Series G *,(4) | 060505385 | n/a | Mar 2012 | Greater of 3-month CME Term SOFR + 66.161 bps or 4% | Mar 15, Jun 15, Sep 15, Dec 15 | Non-cumulative | 3/15/2012 |
Series L Convertible | 060505682 | BAC PrL | Jan 2008 | 7.250% | Jan 30, Apr 30, Jul 30, Oct 30 | Non-cumulative | Non-callable |
Series AA *,(5) | 060505EN0 | n/a | Mar 2015 | 6.100% to, but excluding Mar 17, 2025; 3-month CME Term SOFR + 415.961 bps thereafter | Fixed: Mar 17, Sep 17 Floating Beginning 6/17/2025: Mar 17, Jun 17, Sep 17, Dec 17 |
Non-cumulative | 3/17/2025 |
Series DD *,(5) | 060505EU4 | n/a | Mar 2016 | 6.300% to, but excluding, Mar 10, 2026; 3-month CME Term SOFR + 481.461 bps thereafter | Fixed: Mar 10, Sep 10 Floating Beginning 6/10/2026: Mar 10, Jun 10, Sep 10, Dec 10 |
Non-cumulative | 3/10/2026 |
Series FF *,(5) | 060505FL3 | n/a | Mar 2018 | 5.875% to, but excluding, March 15, 2028; 3-month CME Term SOFR + 319.261 bps thereafter | Fixed: Mar 15, Sep 15 Floating Beginning 6/15/2028: Mar 15, Jun 15, Sep 15, Dec 15 |
Non-cumulative | 3/15/2028 |
Series GG (3) | 060505229 | BAC PrB | May 2018 | 6.000% | Feb 16, May 16, Aug 16, Nov 16 | Non-cumulative | 5/16/2023 |
Series HH (3) | 060505195 | BAC PrK | Jul 2018 | 5.875% | Jan 24, Apr 24, Jul 24, Oct 24 | Non-cumulative | 7/24/2023 |
Series KK (3) | 06053U601 | BAC PrM | Jun 2019 | 5.375% | Mar 25, Jun 25, Sep 25, Dec 25 |
Non-cumulative | 6/25/2024 |
Series LL (3) | 06055H202 | BAC PrN | Sep 2019 | 5.000% | Mar 17, Jun 17, Sep 17, Dec 17 | Non-cumulative | 9/17/2024 |
Series MM *,(5) | 060505FQ2 | n/a | Jan 2020 | 4.300% to, but excluding, Jan 28, 2025; 3-month CME Term SOFR + 292.561 bps thereafter | Fixed: Jan 28, Jul 28 Floating Beginning 4/28/2025: Jan 28, Apr 28, Jul 28, Oct 28 |
Non-cumulative | 1/28/2025 |
Series NN (3) | 06055H400 | BAC PrO | Oct 2020 | 4.375% | Feb 3, May 3, Aug 3, Nov 3 |
Non-cumulative | 11/3/2025 |
Series PP (3) | 06055H608 | BAC PrP | Jan 2021 | 4.125% | Feb 2, May 2, Aug 2, Nov 2 |
Non-cumulative | 2/2/2026 |
Series QQ (3) | 06055H806 | BAC PrQ | Oct 2021 | 4.250% | Feb 17, May 17, Aug 17, Nov 17 |
Non-cumulative | 11/17/2026 |
Series RR (7) | 060505GB4 | n/a | Jan 2022 | 4.375% to, but excluding, Jan 27, 2027; 5-year UST + 276 bps thereafter | Jan 27, April 27, Jul 27, Oct 27 | Non-cumulative | 1/27/2027 |
Series SS (3) | 06055H871 | BAC PrS | Jan 2022 | 4.750% | Feb 17, May 17, Aug 17, Nov 17 |
Non-cumulative | 02/17/2027 |
Series TT (7) | 06055HAB9 | n/a | Apr 2022 | 6.125% to, but excluding, Apr 27, 2027; 5-year UST + 323.1 bps thereafter | Jan 27, Apr 27, Jul 27, Oct 27 | Non-cumulative | 4/27/2027 |
Series 1 *,(6) | 060505633 | BML PrG | Nov 2004 | Greater of 3-month CME Term SOFR + 101.161 bps or 3% | Feb 28, May 28, Aug 28, Nov 28 | Non-cumulative | 11/28/2009 |
Series 2 *,(6) | 060505625 | BML PrH | Mar 2005 | Greater of 3-month CME Term SOFR + 91.161 bps or 3% | Feb 28, May 28, Aug 28, Nov 28 | Non-cumulative | 11/28/2009 |
Series 4 *,(6) | 060505591 | BML PrJ | Nov 2005 | Greater of 3-month CME Term SOFR + 101.161 bps or 4% | Feb 28, May 28, Aug 28, Nov 28 | Non-cumulative | 11/28/2010 |
Series 5 *,(6) | 060505583 | BML PrL | Mar 2007 | Greater of 3-month CME Term SOFR + 76.161 bps or 4% | Feb 21, May 21, Aug 21, Nov 21 | Non-cumulative | 5/21/2012 |
*The floating rate component of the Per Annum Dividend Rate listed for this security reflects the replacement of its original USD LIBOR reference rate with CME Term SOFR plus the applicable tenor spread adjustment prescribed by rules issued by the Board of Governors of the Federal Reserve System as directed by the Adjustable Interest Rate (LIBOR) Act enacted by the U.S. Congress in March 2022. As further explained in our press release on March 31, 2023, for dividend determinations after June 30, 2023, the CME Term SOFR Reference Rate published for the three-month tenor (that corresponds to the three-month USD LIBOR tenor), as administered by CME Group Benchmark Administration, Ltd. (“CME Term SOFR”), plus the three-month tenor spread adjustment (26.161 bps) will be the reference rate for calculations or determinations of applicable dividend or distribution payments for our impacted USD LIBOR preferred stock. The Per Annum Dividend rate listed also includes any credit spread above USD LIBOR that was prescribed in the original terms for the security. Please note that the prospectus linked at left for this security pre-dates the replacement of USD LIBOR with CME Term SOFR and thus only includes its original terms that referenced USD LIBOR for the determination of floating rate dividend payments.
(1) Each series of preferred stock was issued by Bank of America Corporation (the "Corporation"). The final prospectus supplement for each series, if available, is hyperlinked in first column of the table above. For more information about the Corporation's series of preferred stock, including certain voting rights, see the Corporation's Amended and Restated Certificate of Incorporation filed with the SEC.
(2) The Corporation may redeem series of preferred stock on or after the redemption date, in whole or in part, at its option, at the applicable redemption price plus declared and unpaid dividends. Series B and Series L preferred stock do not have early redemption/call rights.
(3) Ownership is held in the form of depositary shares each representing a 1/1000th interest in a share of preferred stock paying a quarterly cash dividend, if and when declared.
(4) Series F and Series G are held by BAC Capital Trust XIII and BAC Capital Trust XIV, respectively. Interests in BAC Capital Trust XIII and BAC Capital Trust XIV are represented by Hybrid Income Term Securities (HITS).
(5) Ownership is held in the form of depositary shares each representing a 1/25th interest in a share of preferred stock, paying a semi-annual cash dividend, if and when declared, until the date the securities first become redeemable, then adjusts to a quarterly cash dividend, if and when declared, thereafter.
(6) Ownership is held in the form of depositary shares, each representing a 1/1200th interest in a share of preferred stock, paying a quarterly cash dividend, if and when declared.
(7) Ownership is held in the form of depositary shares, each representing 1/25th interest in a share of preferred stock, paying a quarterly cash dividend, if and when declared.
For more detail on any announced redemption of these securities, please see Press Releases and Quarterly Earnings.
Note: n/a = not applicable